Second-line therapies after CDK4/6 inhibitor failure in HR-positive/HER2-negative metastatic breast cancer patients: real-world data from the HERMIONE-13 study.

Saved in:
Bibliographic Details
Title: Second-line therapies after CDK4/6 inhibitor failure in HR-positive/HER2-negative metastatic breast cancer patients: real-world data from the HERMIONE-13 study.
Authors: Cazzaniga ME; Phase 1 Research Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.; School of Medicine and Surgery, University of Milano Bicocca, Monza, Italy., Cogliati V; Phase 1 Research Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Rossi E; School of Medicine and Surgery, University of Milano Bicocca, Monza, Italy., Paris I; Division of Gynecologic Oncology, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Borella F; Oncologia Medica, Ospedale Sant'Anna, AOU Città della scienza e della salute, Ospedale Sant'Anna, Turin, Italy., Moretti G; Oncologia Provinciale Azienda USL IRCSS di Reggio Emilia, Reggio Emilia, Italy., Garrone O; Oncologia Medica, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano., Pistelli M; Clinica Oncologica AOU Ospedali Riuniti, Ancona, Italy., Palumbo R; Oncologia Medica, IRCCS Fondazione Salvatore Maugeri, Pavia, Italy., Ferro A; Oncologia Medica, A.P.S.S. Trento, Trent, Italy., Vici P; Divisione Oncologia Medica 2, IRCCS Istituto Nazionale Tumori-IFO Regina Elena, Rome, Italy., De Giorgi U; Istituto Romagnolo per la cura e lo studio dei tumori (IRST-IRCCS), Meldola, Italy., Madaro S; U.O.C Oncologia Ospedale 'G da Saliceto', Piacenza, Italy., Coltelli L; Oncologia Medica Ospedale Civile di Livorno, Azienda USL Toscana Nord Ovest, Livorno, Italy., Giordano M; Oncologia Medica, ASST Lariana, Como, Italy., Gambaro AR; Oncologia Medica, A.S.S.T. Fatebenefratelli Sacco, Milan, Italy., Nicoletti SVL; UO Oncologia, Ospedale degli Infermi, Rimini, Italy., Zustovich F; Oncologia Medica, Ospedale San Martino di Belluno-ULSS 1 Dolomiti, Belluno, Italy., Landucci E; UO Oncologia Medica I, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy., Gamucci T; Oncologia Medica, Ospedale S. Pertini, Rome, Italy., Pepe FF; Phase 1 Research Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Galimberti S; Department of Medicine and Surgery, Bicocca Bioinformatics, Biostatistics and Bioimaging Centre B4, University of Milano Bicocca, Milan, Italy.; Biostatistics and Clinical Epidemiology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Capici S; Phase 1 Research Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Source: ESMO real world data and digital oncology [ESMO Real World Data Digit Oncol] 2026 Jan 06; Vol. 11, pp. 100665. Date of Electronic Publication: 2026 Jan 06 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 9919053637506676 Publication Model: eCollection Cited Medium: Internet ISSN: 2949-8201 (Electronic) Linking ISSN: 29498201 NLM ISO Abbreviation: ESMO Real World Data Digit Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41930299
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Second-line therapies after CDK4/6 inhibitor failure in HR-positive/HER2-negative metastatic breast cancer patients: real-world data from the HERMIONE-13 study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Cazzaniga+ME%22">Cazzaniga ME</searchLink>; Phase 1 Research Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.; School of Medicine and Surgery, University of Milano Bicocca, Monza, Italy.<br /><searchLink fieldCode="AU" term="%22Cogliati+V%22">Cogliati V</searchLink>; Phase 1 Research Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.<br /><searchLink fieldCode="AU" term="%22Rossi+E%22">Rossi E</searchLink>; School of Medicine and Surgery, University of Milano Bicocca, Monza, Italy.<br /><searchLink fieldCode="AU" term="%22Paris+I%22">Paris I</searchLink>; Division of Gynecologic Oncology, Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Borella+F%22">Borella F</searchLink>; Oncologia Medica, Ospedale Sant'Anna, AOU Città della scienza e della salute, Ospedale Sant'Anna, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Moretti+G%22">Moretti G</searchLink>; Oncologia Provinciale Azienda USL IRCSS di Reggio Emilia, Reggio Emilia, Italy.<br /><searchLink fieldCode="AU" term="%22Garrone+O%22">Garrone O</searchLink>; Oncologia Medica, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano.<br /><searchLink fieldCode="AU" term="%22Pistelli+M%22">Pistelli M</searchLink>; Clinica Oncologica AOU Ospedali Riuniti, Ancona, Italy.<br /><searchLink fieldCode="AU" term="%22Palumbo+R%22">Palumbo R</searchLink>; Oncologia Medica, IRCCS Fondazione Salvatore Maugeri, Pavia, Italy.<br /><searchLink fieldCode="AU" term="%22Ferro+A%22">Ferro A</searchLink>; Oncologia Medica, A.P.S.S. Trento, Trent, Italy.<br /><searchLink fieldCode="AU" term="%22Vici+P%22">Vici P</searchLink>; Divisione Oncologia Medica 2, IRCCS Istituto Nazionale Tumori-IFO Regina Elena, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22De+Giorgi+U%22">De Giorgi U</searchLink>; Istituto Romagnolo per la cura e lo studio dei tumori (IRST-IRCCS), Meldola, Italy.<br /><searchLink fieldCode="AU" term="%22Madaro+S%22">Madaro S</searchLink>; U.O.C Oncologia Ospedale 'G da Saliceto', Piacenza, Italy.<br /><searchLink fieldCode="AU" term="%22Coltelli+L%22">Coltelli L</searchLink>; Oncologia Medica Ospedale Civile di Livorno, Azienda USL Toscana Nord Ovest, Livorno, Italy.<br /><searchLink fieldCode="AU" term="%22Giordano+M%22">Giordano M</searchLink>; Oncologia Medica, ASST Lariana, Como, Italy.<br /><searchLink fieldCode="AU" term="%22Gambaro+AR%22">Gambaro AR</searchLink>; Oncologia Medica, A.S.S.T. Fatebenefratelli Sacco, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Nicoletti+SVL%22">Nicoletti SVL</searchLink>; UO Oncologia, Ospedale degli Infermi, Rimini, Italy.<br /><searchLink fieldCode="AU" term="%22Zustovich+F%22">Zustovich F</searchLink>; Oncologia Medica, Ospedale San Martino di Belluno-ULSS 1 Dolomiti, Belluno, Italy.<br /><searchLink fieldCode="AU" term="%22Landucci+E%22">Landucci E</searchLink>; UO Oncologia Medica I, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.<br /><searchLink fieldCode="AU" term="%22Gamucci+T%22">Gamucci T</searchLink>; Oncologia Medica, Ospedale S. Pertini, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Pepe+FF%22">Pepe FF</searchLink>; Phase 1 Research Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.<br /><searchLink fieldCode="AU" term="%22Galimberti+S%22">Galimberti S</searchLink>; Department of Medicine and Surgery, Bicocca Bioinformatics, Biostatistics and Bioimaging Centre B4, University of Milano Bicocca, Milan, Italy.; Biostatistics and Clinical Epidemiology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.<br /><searchLink fieldCode="AU" term="%22Capici+S%22">Capici S</searchLink>; Phase 1 Research Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229919053637506676%22">ESMO real world data and digital oncology</searchLink> [ESMO Real World Data Digit Oncol] 2026 Jan 06; Vol. 11, pp. 100665. <i>Date of Electronic Publication: </i>2026 Jan 06 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Ltd%22">Elsevier Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9919053637506676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2949-8201 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2229498201%22">29498201 </searchLink><i>NLM ISO Abbreviation: </i>ESMO Real World Data Digit Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41930299
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.esmorw.2025.100665
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100665
    Titles:
      – TitleFull: Second-line therapies after CDK4/6 inhibitor failure in HR-positive/HER2-negative metastatic breast cancer patients: real-world data from the HERMIONE-13 study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Cazzaniga ME
      – PersonEntity:
          Name:
            NameFull: Cogliati V
      – PersonEntity:
          Name:
            NameFull: Rossi E
      – PersonEntity:
          Name:
            NameFull: Paris I
      – PersonEntity:
          Name:
            NameFull: Borella F
      – PersonEntity:
          Name:
            NameFull: Moretti G
      – PersonEntity:
          Name:
            NameFull: Garrone O
      – PersonEntity:
          Name:
            NameFull: Pistelli M
      – PersonEntity:
          Name:
            NameFull: Palumbo R
      – PersonEntity:
          Name:
            NameFull: Ferro A
      – PersonEntity:
          Name:
            NameFull: Vici P
      – PersonEntity:
          Name:
            NameFull: De Giorgi U
      – PersonEntity:
          Name:
            NameFull: Madaro S
      – PersonEntity:
          Name:
            NameFull: Coltelli L
      – PersonEntity:
          Name:
            NameFull: Giordano M
      – PersonEntity:
          Name:
            NameFull: Gambaro AR
      – PersonEntity:
          Name:
            NameFull: Nicoletti SVL
      – PersonEntity:
          Name:
            NameFull: Zustovich F
      – PersonEntity:
          Name:
            NameFull: Landucci E
      – PersonEntity:
          Name:
            NameFull: Gamucci T
      – PersonEntity:
          Name:
            NameFull: Pepe FF
      – PersonEntity:
          Name:
            NameFull: Galimberti S
      – PersonEntity:
          Name:
            NameFull: Capici S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 01
              Text: 2026 Jan 06
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2949-8201
          Numbering:
            – Type: volume
              Value: 11
          Titles:
            – TitleFull: ESMO real world data and digital oncology
              Type: main
ResultId 1